AMPE
Ampio Pharmaceuticals, Inc.
OTCHealthcareBiotechnologyUS
Rating:B-
Company Profile
CEO
Michael A. Martino
IPO Date
2010-03-31
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Ampio Pharmaceuticals, Inc.
CEO
Michael A. Martino
IPO Date
2010-03-31
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
| 25,000 |
| $0.30 |
| 26 May 2023 | MARTINO MICHAEL A | director, officer: CEO | P-Purchase | Acquired | 76,890 | $0.29 |
| 17 May 2023 | BUCHI J KEVIN | director | P-Purchase | Acquired | 32,534 | $0.27 |
| 16 May 2023 | BUCHI J KEVIN | director | P-Purchase | Acquired | 44,026 | $0.25 |
| 16 May 2023 | BUCHI J KEVIN | director | P-Purchase | Acquired | 23,440 | $0.24 |
| 12 May 2023 | Stevens David R | director | P-Purchase | Acquired | 45,000 | $0.22 |
| 12 May 2023 | Stevens David R | director | P-Purchase | Acquired | 25,000 | $0.21 |
| 12 May 2023 | Stevens David R | director | P-Purchase | Acquired | 25,000 | $0.22 |
| 10 Feb 2022 | Bar-Or David | director | A-Award | Acquired | 75,000 | $0.53 |